Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 37, Issue 2, Pages 341-+Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/ATVBAHA.116.308695
Keywords
coronary artery disease; endothelial cells; microRNAs; myocardial infarction; real-time polymerase chain reaction
Categories
Funding
- Swiss National Research Foundation Sonderprogramm Universitare Medizin [33CM30-124112/1]
- Uniscientia Foundation
- IFB-Tx [BMBF 01EO0802]
- Zurich Center for Integrative Human Physiology
- DFG [TH 903/7-2]
- AstraZeneca, Zug, Switzerland
- Eli Lilly, Indianapolis
- Medtronic, Tollachenaz, Switzerland
- Zurich Heart House-Foundation for Cardiovascular Research
- Swiss National Science Foundation [PZ00P3_126621, PZ00P3_142300]
- Swiss National Science Foundation (SNF) [PZ00P3_126621] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Objective-Proangiogenic effects of mobilized bone marrow-derived stem/progenitor cells are essential for cardiac repair after myocardial infarction. MicroRNAs (miRNA/miR) are key regulators of angiogenesis. We investigated the differential regulation of angio-miRs, that is, miRNAs regulating neovascularization, in mobilized CD34(+) progenitor cells obtained from patients with an acute ST-segment-elevation myocardial infarction (STEMI) as compared with those with stable coronary artery disease or healthy subjects. Approach and Results-CD34(+) progenitor cells were isolated from patients with STEMI (on day 0 and day 5), stable coronary artery disease, and healthy subjects (n=27). CD34(+) progenitor cells of patients with STEMI exhibited increased proangiogenic activity as compared with CD34(+) cells from the other groups. Using a polymerase chain reaction-based miRNA-array and real-time polymerase chain reaction validation, we identified a profound upregulation of 2 known angio-miRs, that are, miR-378 and let-7b, in CD34(+) cells of patients with STEMI. Especially, we demonstrate that miR-378 is a critical regulator of the proangiogenic capacity of CD34(+) progenitor cells and its stimulatory effects on endothelial cells in vitro and in vivo, whereas let-7b upregulation in CD34(+) cells failed to proof its effect on endothelial cells in vivo. Conclusions-The present study demonstrates a significant upregulation of the angio-miRs miR-378 and let-7b in mobilized CD34(+) progenitor cells of patients with STEMI. The increased proangiogenic activity of these cells in patients with STEMI and the observation that in particular miR-378 regulates the angiogenic capacity of CD34(+) progenitor cells in vivo suggest that this unique miRNA expression pattern represents a novel endogenous repair mechanism activated in acute myocardial infarction.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available